DISCLAIMER — Not financial advice. Educational content only, not an offer or solicitation to buy or sell any security. Biotech and small/mid-cap stocks are highly speculative and volatile and can result in a partial or total loss of capital. Do your own research and consult a licensed advisor where appropriate. / Contenuti a solo scopo informativo e didattico, non costituiscono consulenza finanziaria né offerta o sollecitazione al pubblico risparmio ai sensi delle normative CONSOB e SEC. Le azioni biotech e le small/mid cap sono strumenti altamente speculativi e volatili e possono comportare la perdita parziale o totale del capitale investito. Si raccomanda di effettuare sempre le proprie ricerche e, se necessario, di rivolgersi a un consulente abilitato.

Merlintrader Trading Pub
Biotech catalyst news and analysis. FDA PDUFA tracker
Thank you all for being here. I hope you enjoy the site and find it useful. Always remember that I am not a guru, nor a licensed professional, just a simple trader like you, so I will never get tired of saying it: please double-check and verify every piece of information with your own research on official sources. The only thing I can say with certainty is this: not losing money is already a gain, so always stay careful. :)
Thank you all for being here. I hope you enjoy the site and find it useful. Always remember that I am not a guru, nor a licensed professional, just a simple trader like you, so I will never get tired of saying it: please double-check and verify every piece of information with your own research on official sources. The only thing I can say with certainty is this: not losing money is already a gain, so always stay careful. :)

Merlintrader Trading Pub
Biotech catalyst news and analysis. FDA PDUFA tracker
? Quince Therapeutics (QNCX)
? Timeline Eventi
- Dic 2024: Crollo post-aggiornamento strategico e revisione pipeline.
- Gen–Mar 2025: Focus su asset CNS dopo dismissione dei programmi non core.
- Apr 2025: Pubblicazione dati preclinici su piattaforma di delivery mirata.
- Set 2025: Conferma mantenimento liquidità sufficiente per 2026.
? Dati Finanziari
- Cassa: ~110 M USD (Q2 2025)
- Market Cap: ~60 M USD
- Azioni in circolazione: ~45 M
- Float: ~40 M
- Debito: nessuno rilevante
? Prossimi Catalysts
- Annuncio partnership strategica (atteso entro Q4 2025)
- Update programma preclinico principale (fine 2025)
? Potenziale d’impatto
Un accordo di co-sviluppo o M&A parziale potrebbe più che raddoppiare la valutazione attuale, vista la solida posizione di cassa rispetto alla capitalizzazione.
? Link Utili
⚠️ Informazioni a scopo divulgativo. Nessuna raccomandazione di investimento.
Scanner for active traders
Try ChartsWatcher free, then unlock 10% OFF with SAVE10
ChartsWatcher is a real-time scanner for momentum traders: fast movers, unusual volume and rotations — so you can focus on the few tickers that matter right now, instead of watching hundreds of charts.
Start with the free version. When you upgrade, use SAVE10 for 10% OFF your first paid period.
Start free – then use SAVE10
No credit card required to start. Apply SAVE10 when upgrading.
Recommended platform
One platform. All your brokers.
Medved Trader connects multiple brokers in one workspace, with pro charts, hotkeys and fast execution — without changing your broker accounts.
A single cockpit for positions, Level II and multi-broker order routing, built for active day & swing traders.
Get 1 Month Free ➔
Multi-broker workflow + customizable layouts in one platform.